Advertisement
Advertisement

DYAI

DYAI logo

Dyadic International, Inc.

1.00
USD
Sponsored
-0.02
-1.96%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

1.00

0.00
0.00%

Dyadic International, Inc. Profile

About

Dyadic International, Inc. is a leading genomics company with the groundbreaking technology that brings nature to the marketplace. Dyadic is poised to become a global leader in proteomics through the discovery, development, and manufacturing of novel products derived from the DNA of complex living organisms including humans found in the earth's biodiversity. Using its integrated technology platform, Dyadic develops biological products such as proteins, enzymes, polypeptides and small molecules for applications in large segments of the agricultural, industrial, chemical and biopharmaceutical industries. By utilizing a proprietary host organism, Dyadic's `one-stop shop` technology rapidly discovers and expresses eukaryotic genes the genes of complex living organisms and then manufactures those unique biological products for commercial application. Dyadic's systems overcome the inadequacy of existing gene discovery and product development techniques.

Info & Links

CEO

Mark A. Emalfarb

Headquarters

1044 North U.S. Highway One, Suite 201
JUPITER, FL 33477, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.dyadic.com

Auditor

Crowe LLP

Share holders

43

Employees

5

Dyadic International, Inc. Statistics

Valuation Measures

Market Capitalization2

36.44M

Enterprise Value

36.32M

Enterprise Value/EBITDA(ttm)

-5.13

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

9.81

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

27.33%

Operating Margin(ttm)

-192.40%

Profit Margin(ttm)

-202.08%

Return on Equity(ttm)

-1005.45%

Return on Invested Capital(ttm)

-133.34%

Return on Assets(ttm)

-77.64%

Income Statement

Revenue(ttm)

3.81M

Revenue Per Share(ttm)

0.10

Gross Profit(ttm)

993.60K

EBITDA(ttm)3

-7.08M

Net Income Available to Common(ttm)

-7.29M

Diluted EPS(ttm)

-0.23

Share Statistics

Beta (5Y Monthly)

1.12

52-Week Change

5.27%

S&P 500 52-Week Change

21.41%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

36.44M

Dividend Yield

0.00%

Float4

28.82M

% Held by Insiders

20.90%

% Held by Institutions

27.95%

Balance Sheet

Total Cash(mrq)

6.52M

Total Cash Per Share(mrq)

0.18

Total Debt(mrq)

5.03M

Total Debt/Equity(mrq)

-1234.49%

Current Ratio(mrq)

2.42%

Quick Ratio(mrq)

2.42%

Book Value Per Share(mrq)

-0.01

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.05

Free Cash Flow(ytd)

-1.96M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement